All News

States are up in the air about their discount card programs following the passage of the Medicare drug benefit legislation, which has a provision for an Rx card program

Clinicians can now treat patients with bipolar depression using the first drug approved in the U.S. for this indication. The FDA recently approved olanzapine/fluoxetine (Symbyax, Eli Lilly) for the treatment of depressive episodes associated with bipolar disorder. Symbyax is currently available in pharmacies.

Following in the footsteps of Walgreens, CVS announced that it will not participate in future health plan contracts requiring refill scripts to be filled by mail order pharmacies.